Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Enerlyte
Active Ingredients: Glucose monohydrate 72.65%w/w
Potassium chloride 6.12%w/w
Sodium acid citrate 10.82%w/w
Sodium chloride 9.59%w/w
Dosage Form: Powder for oral solution
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Cipla Limited, Kurkumbh Village, Taluka - Daund, District - Pune, Maharashtra State, India
Product: Solox
Active Ingredient: Lansoprazole 30mg
Dosage Form: Capsule
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Liconsa SA, Azuqueca de Henares, Guadalajara, Spain
Product: Vistil
Active Ingredient: Polyvinyl alcohol 1.4%w/v
Dosage Form: Eye drops, solution
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Tubilux Pharma SpA, Pomezia, Rome, Italy
Dated this 14th day of October 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).